BSE filing, NSE: GVT&D. Summary written from the filing by ALFA Finder's alert engine.
GE Vernova T&D India Ltd: key numbers
- Share price
- ₹4,020.00
- Market cap
- ₹1,02,931 Cr
- Revenue (annual)
- ₹6,206 Cr
- Net profit (annual)
- ₹1,233 Cr
- P/E (TTM)
- 78.9×Sector 52.8×
- Promoter holding
- 51.00%+0.00% QoQ
- FII holding
- 19.16%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GE Vernova T&D India Ltd
All →GE Vernova T&D India Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹2,027 Cr (+32% YoY), PAT ₹431 Cr (+44%), EBITDA margin 27.1%. H1 revenue and PAT both up about 35%. Q2 order intake +52%.
GE Vernova T&D India Q2 FY27 Results: Net Profit ₹431.4 Cr, Up 44.0% YoY
GE Vernova T&D India approved unaudited standalone results for the quarter ended 30 September 2026. Quarterly net profit rose to Rs.431.4 crore from Rs.299.5 crore.
- Key figure
- Net profit ₹431.4 Cr · +44.0% YoY
GE Vernova T&D India Other Announcement
GE Vernova T&D India Limited filed the Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, as required by SEBI regulations.
GE Vernova T&D India Board Meeting Date
GE Vernova T&D India will hold a board meeting on October 30, 2026, to consider and approve un-audited financial results for the quarter ended September 30, 2026.
GE Vernova T&D India Other Announcement
The company submitted the quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, regarding securities dematerialization processes for the quarter ended September 30, 2026.
GE Vernova T&D India Other Announcement
GE Vernova T&D India Limited received an unsolicited Environmental, Social and Governance (ESG) rating of 'Crisil ESG 68' and 'CRISIL Core ESG 74' from CRISIL.
Other results update announcements
All →Artemis Medicare Services Results Update
Artemis Medicare reported Q2 FY27 consolidated revenue up 13.2% and PAT up 3.7% year-on-year. Adjusted EBITDA rose 22.7%, with the Raipur hospital launched in July 2026.
Advait Energy Transitions Results Update
Advait Energy reported Q2 FY27 consolidated revenue of ₹220.9 crore, up 40.8%, and PAT of ₹19.18 crore, up 88.5%. Its order book reached ₹1,574.8 crore.
- Order book
- ₹1,575 Cr
Lodha Developers Results Update
Lodha reported Q2 FY27 PAT of Rs.1,013 crore, up 28% YoY, and expects to beat full-year profit guidance. Pre-sales reached Rs.5,037 crore in the quarter.
Crizac Results Update
Crizac reported Q2 FY27 Total Income down 34.5% YoY to ₹1,112 Mn and PAT of ₹369 Mn. An interim dividend of ₹4 per share was declared.
Ind-Swift Laboratories Results Update
Ind-Swift Laboratories reported Q2 FY27 revenue up 50% to ₹234.89 crore and PAT up 3.5x to ₹31.03 crore. Operating EBITDA margin rose to 18.02%.
Syrma SGS Technology Results Update
Syrma SGS reported Q2 FY27 consolidated revenue of Rs.19,995 Mn and PAT of Rs.1,242 Mn. Revenue rose 73% year-on-year, with EBITDA of Rs.2,031 Mn.